Innovent Biologics receives US FDA clearance to initiate phase 1 clinical trial of novel oral GLP-1R agonist, IBI3032: San Francisco Wednesday, August 6, 2025, 14:00 Hrs [IST] Inn ...

Three presentations at ADA 2025 highlighted the therapeutic potential of icovamenib across multiple aspects of metabolic health:In patients with type 2 diabetes (T2D) not achieving glycemic targets, ...

Anything that’s human is mentionable, and anything that is mentionable can be more manageable. When we can talk about our ...

For the second quarter, total revenues increased 9% to $9.2 billion in comparison to the second quarter of 2024. Product sales grew 9%, driven by 13% volume g ...

Prediabetes is a condition in which blood sugar levels are higher than normal but not yet high enough to be diagnosed as full-fledged diabetes. It's estimated that one in three American adults has ...